Global CNS Therapeutics Market Size study, by Type (Neurodegenerative, Mood Disorders, Schizophrenia, Autism, Depression), by Application (Hospital Use, Clinic Use, Household, Others) and Regional Forecasts 2018-2025
- BIZ2866189
- 200 Pages
- December 2018
- Healthcare
Global CNS Therapeutics Market valued approximately USD 82.3 billion in 2017 is anticipated to grow with a healthy growth rate of more than 5.93% over the forecast period 2018-2025. The major driving factor of global CNS Therapeutics market are rising cases of mental illness and increasing awareness regarding psychiatric disorders. In addition, expanding geriatric population and rising prevalence of lifestyle associated CNS disorders are some other major driving factors which boosting the market. However, one of the major restraining factor of CNS Therapeutics market is several side effects of CNS therapeutics such as weight gain, insomnia, lowered libido, tremors and agitation which hampers the market growth. It refers CNS disorders that effect the structure or function of the brain or spinal cord such as Parkinson’s, disease, epilepsy, Alzheimer disease, anxiety, depression and bipolar disorders. There are many key advantages of CNS therapeutic such as it has the benefit to high concentration in brain, it reduces systematic side effects, large drug distribution volume, it has flexible therapy protocol and it has consistent drug concentration. The major trend of global CNS therapeutics market is increase in adoption of new generation drugs. The regional analysis of Global CNS Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
The major market player included in this report are:
• Pfizer
• Janseen Pharmaceuticals
• Allergan
• Lundbeck
• Teva
• Camber Pharmaceuticals
• Zhejiang Haisen Pharmaceuticals
• Jewim Pharmaceuticals
• Cipla
• Merck Sharp & Dohme Corp.
• Eli Lilly
• GlaxoSmithKline
• Novartis
• LUPIN
• ZYDUS PHARMS
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
? Neurodegenerative
? Mood Disorders
? Schizophrenia
? Autism
? Depression
By Application:
? Hospital Use
? Clinic Use
? Household
? Others
By Regions:
? North America
o U.S.
o Canada
? Europe
o UK
o Germany
? Asia Pacific
o China
o India
o Japan
? Latin America
o Brazil
o Mexico
? Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
Target Audience of the Global CNS Therapeutics Market in Market Study:
? Key Consulting Companies & Advisors
? Large, medium-sized, and small enterprises
? Venture capitalists
? Value-Added Resellers (VARs)
? Third-party knowledge providers
? Investment bankers
? Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. CNS Therapeutics Market, by Type, 2015-2025 (USD Billion)
1.3.2. CNS Therapeutics Market, by Application, 2015-2025 (USD Billion)
1.3.3. CNS Therapeutics Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. CNS Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. CNS Therapeutics Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. CNS Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. CNS Therapeutics Market, by Type
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. CNS Therapeutics Market, Sub Segment Analysis
5.4.1. Neurodegenerative Diseases
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Mood Disorders
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.3. Schizophrenia
5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.4. Autism
5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.5. Depression
5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. CNS Therapeutics Market, by Application
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Key Market Players
6.4. CNS Therapeutics Market, Sub Segment Analysis
6.4.1. Hospital Use
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. Clinic Use
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Household
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Other
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. CNS Therapeutics Market, by Regional Analysis
7.1. CNS Therapeutics Market, Regional Market Snapshot (2015-2025)
7.2. North America CNS Therapeutics Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3. Europe CNS Therapeutics Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. France
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Rest of Europe
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4. Asia CNS Therapeutics Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5. Latin America CNS Therapeutics Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Pfizer
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Janseen Pharmaceuticals
8.3.3. Allergan
8.3.4. Lundbeck
8.3.5. Teva
8.3.6. Camber Pharmaceuticals
8.3.7. Zhejiang Haisen Pharmaceuticals
8.3.8. Jewim Pharmaceuticals
8.3.9. Cipla
8.3.10. Merck Sharp & Dohme Corp.
8.3.11. Eli Lilly
8.3.12. GlaxoSmithKline
8.3.13. Novartis
8.3.14. LUPIN
8.3.15. ZYDUS PHARMS
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF CNS THERAPEUTICS MARKET
TABLE 3. CNS THERAPEUTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. CNS THERAPEUTICS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. CNS THERAPEUTICS MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 8. CNS THERAPEUTICS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
